Child Mind Institute Inc.

Child Mind Institute Inc., a New York-based tax-exempt nonprofit organization, conducts federal research and services work in neuroimaging, neuroscience, and child mental health as a prime grant recipient (55% of awards) and as a sub-recipient on research grants (45% of awards). The organization operates exclusively in the federal grant space; it holds no federal contracts or contract vehicles.

Child Mind Institute's capability footprint centers on pediatric neuroscience research, neuroimaging data processing and analysis, psychiatric epidemiology, and school-based mental health intervention development. The organization serves as principal investigator or co-investigator on large-scale longitudinal studies and neuroimaging harmonization projects. Recent representative work includes a $600,000 project grant from the Substance Abuse and Mental Health Services Administration (CFDA 93.532, awarded September 2026, running through September 2031) to develop and nationally disseminate RISE, a dialectical behavior therapy-informed emotion regulation protocol for school-based mental health settings targeting children and youth ages 5-18 affected by trauma and emotional dysregulation, with initial capacity development in New York City and the San Mateo County and Bay Area region. As a prime recipient, Child Mind Institute also received project grants from the National Institute of Mental Health on autism neurosubtypes identification (April 2023, running through January 2028), receptor architecture and functional brain networks across species (September 2024, running through July 2027), brain microstructure and functional dynamics integration (May 2025, running through February 2028), and neuroimaging pipeline robustness (August 2022, running through July 2026). The organization received a $102,218.75 purchase order from the National Institute on Drug Abuse (August 2022, completed September 2023) for tracking homeostatic regulatory domains in youth in the general community as part of the Health Brain Network supplement.

Customer concentration is narrow and monolithic: the National Institute of Mental Health accounts for 26 of 31 awards with combined potential value of $24,000; the National Institute on Drug Abuse holds 2 awards worth $324,000; the Substance Abuse and Mental Health Services Administration, the National Institute of Child Health and Human Development, and the National Institute of Diabetes and Digestive and Kidney Diseases each hold one award. All five customers are divisions or centers within the Department of Health and Human Services.

As a sub-recipient, Child Mind Institute partners on research grants led by the Research Foundation for Mental Hygiene Inc., Columbia University, the University of Connecticut, the University of Pennsylvania, Stanford, the University of Minnesota, and the Research Foundation of the City University of New York. Sub-award work includes neuroimaging data processing, analytic planning, quality assessment, clinical protocol design, and longitudinal statistical modeling on projects spanning emotion regulation development, autism neuroimaging harmonization, prenatal stress and psychopathology, and brain imaging infrastructure (neuroimaging preprocessing workflows and Configurable Pipeline for the Analysis of Connectomes integration). Child Mind Institute's sub-award role brings specialized neuroimaging informatics and neurodevelopmental epidemiology expertise to larger multi-institutional research consortia, particularly within the NIH BRAIN Initiative and National Child Traumatic Stress Initiative contexts.

Activity has grown from two awards in 2022 to nine in 2025, with three awards completing in the next twenty-four months. The organization's federal footprint is research-grant-dominated with no procurement contracting exposure.